<?xml version="1.0" encoding="UTF-8"?>
<p id="p0410">Measles was the first virus clearly identified to cause increased susceptibility to other microbial secondary infections. Most often, measles-associated deaths are caused by severe, overwhelming pneumonia and diarrhea.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> Suppression of delayed hypersensitivity has been identified in tuberculin-sensitized individuals many weeks after complete resolution of MV infection (
 <xref rid="f0020" ref-type="fig">Fig. 49.3C</xref>).
 <xref rid="bib19" ref-type="bibr">
  <sup>19</sup>
 </xref> Furthermore, several weeks after successful MV recovery, increased susceptibility to other infections has been reported, and T cell function and 
 <italic>in vitro</italic> proliferation of T cells in response to mitogens has been shown to be markedly decreased (
 <xref rid="f0025" ref-type="fig">Fig. 49.4A and B</xref> ).
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib20" ref-type="bibr">
  <sup>20</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> Immunosuppression occurs during a period of intense immune activation that occurs during the onset of the MV rash and anti-MV immune responses (
 <xref rid="f0020" ref-type="fig">Fig. 49.3C and D</xref>). Lymphopenia, skewing of Th2-like chemokine polarized responses, and suppression of lymphocyte proliferation have also been documented (
 <xref rid="f0020" ref-type="fig">Fig. 49.3D</xref>). MV infection causes decreases in T and B cells in the blood during the MV rash period.
 <xref rid="bib22" ref-type="bibr">22</xref>, 
 <xref rid="bib23" ref-type="bibr">23</xref>, 
 <xref rid="bib24" ref-type="bibr">24</xref>, 
 <xref rid="bib25" ref-type="bibr">25</xref> Altered trafficking and increased apoptosis of MV-infected and uninfected lymphocytes contribute to the development of lymphopenia.
 <xref rid="bib22" ref-type="bibr">
  <sup>22</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib26" ref-type="bibr">26</xref>, 
 <xref rid="bib27" ref-type="bibr">27</xref>, 
 <xref rid="bib28" ref-type="bibr">28</xref>, 
 <xref rid="bib29" ref-type="bibr">29</xref>, 
 <xref rid="bib30" ref-type="bibr">30</xref> While lymphocyte numbers rapidly return to normal in the blood after the rash resolves, immunologic abnormalities persist.
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib22" ref-type="bibr">
  <sup>22</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib31" ref-type="bibr">
  <sup>31</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib32" ref-type="bibr">
  <sup>32</sup>
 </xref> Immune suppression, Th2 cytokine polarization of CD4
 <sup>+</sup> T cells, and Treg induction have been associated with indirect immunosuppression caused by MV infection.
 <xref rid="bib33" ref-type="bibr">
  <sup>33</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib34" ref-type="bibr">
  <sup>34</sup>
 </xref> MV infection is also associated with suppression of IL-12 expression, lymphocyte CD30 expression, and IL-4, IL-10, and IL-13 expression after rash resolution.
 <xref rid="bib35" ref-type="bibr">35</xref>, 
 <xref rid="bib36" ref-type="bibr">36</xref>, 
 <xref rid="bib37" ref-type="bibr">37</xref> Reduction of IL-12 production reduces T cell expression of type I cytokines, particularly IFN-γ
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib32" ref-type="bibr">
  <sup>32</sup>
 </xref> (
 <xref rid="f0020" ref-type="fig">Fig. 49.3D</xref>). It is possible that MV interacts with the complement regulatory molecule CD46 in polarizing Th2-like cytokine production, causing activation of signaling cascades that modify cell function, although this interaction is not firmly established.
 <xref rid="bib38" ref-type="bibr">
  <sup>38</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib39" ref-type="bibr">
  <sup>39</sup>
 </xref> The MV-CD46 interaction may alter innate immunity by selectively downregulating receptor expression.
 <xref rid="bib40" ref-type="bibr">40</xref>, 
 <xref rid="bib41" ref-type="bibr">41</xref>, 
 <xref rid="bib42" ref-type="bibr">42</xref>, 
 <xref rid="bib43" ref-type="bibr">43</xref>, 
 <xref rid="bib44" ref-type="bibr">44</xref>, 
 <xref rid="bib45" ref-type="bibr">45</xref>, 
 <xref rid="bib46" ref-type="bibr">46</xref> This would increase susceptibility to complement-mediated lysis of MV-infected cells, and decrease antigen presenting cell production of IL-12
 <xref rid="bib47" ref-type="bibr">
  <sup>47</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib48" ref-type="bibr">
  <sup>48</sup>
 </xref> and crosslinking of CD46 on T cells, leading to the induction of regulatory CD4
 <sup>+</sup> T cells and enhanced IL-10 levels.
 <xref rid="bib49" ref-type="bibr">
  <sup>49</sup>
 </xref> These interactions would induce Th2-like polarization that would favor B cell maturation, provide lifelong MV antibody memory, and protect against MV re-infection. This polarization, however, would also depress APC activation and Th1-like responses to new pathogens.
</p>
